Literature DB >> 9825933

Mounting evidence against current histogenetic concepts for salivary gland tumorigenesis.

I Dardick1.   

Abstract

Various morphological observations of salivary gland tumors are frequently used to support histogenetic concepts, such as the semipluripotential bicellular reserve cell hypothesis, for these tumors. Singularly, evidence in support of this hypothesis remains unavailable. Indeed, physiological evidence from studies of salivary glands have long existed proving the semipluripotential bicellular reserve cell hypothesis was incorrect. More recent studies reconfirm this and show that all cell types in these complex glands are quite capable of replication and, therefore, of being involved in tumorigenic processes. The demise of the bicellular reserve cell hypothesis is long overdue.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9825933

Source DB:  PubMed          Journal:  Eur J Morphol        ISSN: 0924-3860


  4 in total

Review 1.  A perspective of comparative salivary and breast pathology. Part I: microstructural aspects, adaptations and cellular events.

Authors:  Asterios Triantafyllou; Jennifer L Hunt; Kenneth O Devaney; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-05-07       Impact factor: 2.503

2.  Secretory myoepithelial carcinoma: a histologic and molecular survey and a proposed nomenclature for mucin producing signet ring tumors.

Authors:  Jassem M Bastaki; Bibianna M Purgina; Sanja Dacic; Raja R Seethala
Journal:  Head Neck Pathol       Date:  2014-01-21

3.  Well-differentiated acinic cell carcinoma with lymphoid stroma associated with osteoclast-like giant cells of the parotid gland in children: a case report and literature review.

Authors:  Zhengjin Liu; Chao Pan; Ping Yin; Hongfeng Liao
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

4.  Early to late sparing of radiation damage to the parotid gland by adrenergic and muscarinic receptor agonists.

Authors:  R P Coppes; L J Zeilstra; H H Kampinga; A W Konings
Journal:  Br J Cancer       Date:  2001-09-28       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.